$40,000 of MYRIAD GENETICS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Prior Authorization for Medicare Advantage."
You can find more data on corporate lobbying on Quiver Quantitative.
MYGN Hedge Fund Activity
We have seen 129 institutional investors add shares of MYGN stock to their portfolio, and 103 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 4,592,264 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $24,384,921
- DISCIPLINED GROWTH INVESTORS INC /MN removed 3,979,736 shares (-84.1%) from their portfolio in Q2 2025, for an estimated $21,132,398
- EARNEST PARTNERS LLC removed 3,977,292 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $21,119,420
- MORGAN STANLEY added 2,939,498 shares (+182.1%) to their portfolio in Q2 2025, for an estimated $15,608,734
- SEI INVESTMENTS CO removed 2,526,761 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $13,417,100
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,277,256 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,092,229
- BANK OF AMERICA CORP /DE/ removed 2,214,609 shares (-84.2%) from their portfolio in Q2 2025, for an estimated $11,759,573
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MYGN Analyst Ratings
Wall Street analysts have issued reports on $MYGN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 05/15/2025
- Goldman Sachs issued a "Buy" rating on 05/07/2025
- Raymond James issued a "Outperform" rating on 05/07/2025
To track analyst ratings and price targets for MYGN, check out Quiver Quantitative's $MYGN forecast page.
MYGN Price Targets
Multiple analysts have issued price targets for $MYGN recently. We have seen 6 analysts offer price targets for $MYGN in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Sung Ji Nam from Scotiabank set a target price of $6.0 on 05/21/2025
- Dave Weiner from Piper Sandler set a target price of $9.0 on 05/15/2025
- Brandon Couillard from Wells Fargo set a target price of $6.0 on 05/08/2025
- Matthew Sykes from Goldman Sachs set a target price of $8.0 on 05/07/2025
- Lu Li from UBS set a target price of $7.0 on 05/07/2025
- Andrew Cooper from Raymond James set a target price of $10.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
